GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

Capacity expansion at Active Pharmaceutical Ingredient facility in Lindesnes, Norway, contributes to GE Healthcare’s aim to produce 30 million more doses of contrast media per year by 2025 This step reinforces GE Healthcare’s broader commitment to address growing future demand for contrast media, which it expects to double in the next ten years Lindesnes, 17... Read more